Department of Kinesiology, University of Waterloo, Waterloo, ON, Canada;
Int J Gen Med. 2009 Dec 29;2:227-42. doi: 10.2147/ijgm.s5981.
The objective of this paper is to provide an overview of the recent developments in muscle physiology and biochemistry in general, and with respect to chronic obstructive pulmonary disease (COPD) specifically. As a way of illustration, we have presented data on the remodeling that occurs in vastus lateralis in two patients with COPD (COPD #1, forced expiratory volume in one second/forced vital capacity [FEV(1)/FVC] = 63%; COPD #2, FEV(1)/FVC = 41%) exhibiting differences in muscle wasting as compared to healthy controls (CON; FEV(1)/FVC = 111 +/- 2.2%, n = 4). Type I fibers percentages were lower in both COPD #1 (16.7) and COPD #2 (24.9) compared to CON (57.3 +/- 5.2). Cross sectional area of the type I fibers of the patients ranged between 65%-68% of CON and for the type II subtypes (IIA, IIAX, IIX) between 74% and 89% (COPD #1) and 17%-32% (COPD #2). A lower number of capillary contacts were observed for all fiber types in COPD #1 but not COPD #2. Lower concentrations of adenosine triphosphate (ATP) (24%-26%) and phosphocreatine (18%-20%), but not lactate occurred in COPD. In contrast to COPD #1, who displayed normal glucose transporter content, GLUT1 and GLUT4 were only 71% and 54%, respectively of CON in COPD #2. Lower monocarboxylate contents were found for MCT1 in both COPD #1 (63%) and COPD #2 (41%) and for MCT4 (78%) in COPD #1. Maximal oxidative enzyme activities (V(max)) for COPD #2 ranged between 37% (succinic dehydrogenase) and 70% (cytochrome C oxidase) of CON. For the cytosolic enzymes, V(max) ranged between 89% (hexokinase) to 31% (pyruvate kinase) of CON. Depressions were also observed in V(max) of the Na(+)-K(+)-ATPase for COPD #1 (66% of CON) but not COPD #2 (92% of CON) while V(max) of the Ca(2+)-ATPase was near normal in COPD #1 (84% CON). It is concluded that disturbances can occur in muscle to a wide range of excitation, contraction and metabolic processes in COPD.
本文旨在概述肌肉生理学和生物化学的最新进展,特别是针对慢性阻塞性肺疾病(COPD)。为了说明问题,我们提供了两名 COPD 患者(COPD#1,一秒用力呼气量/用力肺活量[FEV1/FVC] = 63%;COPD#2,FEV1/FVC = 41%)和健康对照者(CON;FEV1/FVC = 111 +/- 2.2%,n = 4)股外侧肌发生重塑的相关数据。与 CON(57.3 +/- 5.2)相比,COPD#1(16.7)和 COPD#2(24.9)的 I 型纤维比例均较低。患者的 I 型纤维横截面积范围为 CON 的 65%-68%,II 型纤维亚型(IIA、IIAX、IIX)的横截面积范围为 CON 的 74%-89%(COPD#1)和 17%-32%(COPD#2)。在 COPD#1 中,所有纤维类型的毛细血管接触均减少,但在 COPD#2 中未见减少。COPD 中还发现三磷酸腺苷(ATP)(24%-26%)和磷酸肌酸(18%-20%)浓度降低,但乳酸水平正常。与 COPD#1 不同,后者葡萄糖转运蛋白含量正常,GLUT1 和 GLUT4 分别为 CON 的 71%和 54%。在 COPD#1 中,MCT1 和 MCT4 的单羧酸含量分别降低 63%和 41%,在 COPD#2 中分别降低 78%。COPD#2 的最大氧化酶活性(Vmax)范围为 CON 的 37%(琥珀酸脱氢酶)至 70%(细胞色素 C 氧化酶)。对于胞质酶,Vmax 范围为 CON 的 89%(己糖激酶)至 31%(丙酮酸激酶)。COPD#1 的 Na+-K+-ATP 酶 Vmax 降低(CON 的 66%),但 COPD#2 未见降低(CON 的 92%),而 COPD#1 的 Ca2+-ATP 酶 Vmax 接近正常(CON 的 84%)。总之,COPD 患者的肌肉可能会出现广泛的兴奋、收缩和代谢过程紊乱。